CSPC Pharmaceutical Group Schedules Board Meeting for Quarterly Results

Confident Investing Starts Here:

CSPC Pharmaceutical Group ( (HK:1093) ) has shared an announcement.

CSPC Pharmaceutical Group Limited has announced a board meeting scheduled for May 29, 2025, to approve the unaudited first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance for the first quarter of 2025, which could impact its market positioning and stakeholder confidence.

The most recent analyst rating on (HK:1093) stock is a Buy with a HK$10.26 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.

More about CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacture, and sale of pharmaceutical products.

YTD Price Performance: 23.25%

Average Trading Volume: 145,397,173

Technical Sentiment Signal: Buy

Current Market Cap: HK$67.73B

For a thorough assessment of 1093 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

No Byline Policy

Editorial Guidelines

Corrections Policy

Source